Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library

We have developed a novel competitive method to select from a phage display library a single chain Fv which is able to mimic the α‐bungarotoxin binding site of the muscle nicotinic receptor. The single chain Fv was selected from a large synthetic library using α‐bungarotoxin‐coated magnetic beads. Toxin‐bound phages were then eluted by competition with affinity purified nicotinic receptor. Recognition of the toxin by the anti‐α‐bungarotoxin single chain Fv was very similar to that of the receptor, such as indicated by the epitope mapping of α‐bungarotoxin through overlapping synthetic peptides. Moreover, several positively charged residues located in the toxin second loop and in the C‐terminal region were found to be critical, to a similar extent, for toxin recognition by the single chain Fv and the receptor. However, although the anti‐α‐bungarotoxin single chain Fv seems to mimic the toxin binding site of the nicotinic receptor, it does not bind other nicotinic agonists or antagonists. Our results suggest that competitive selection of anti‐ligand antibody phages can allow the production of receptor‐mimicking molecules directly and exclusively targeted at one specific ligand. Since physiologically and pharmacologically different ligands can produce opposite effects on receptor functions, such selective ligand decoys can have important therapeutic applications.

[1]  T. Lentz Differential binding of nicotine and alpha-bungarotoxin to residues 173-204 of the nicotinic acetylcholine receptor alpha 1 subunit. , 1995, Biochemistry.

[2]  T. Lentz,et al.  Amino acids within residues 181-200 of the nicotinic acetylcholine receptor alpha1 subunit involved in nicotine binding. , 1998, Biochemical pharmacology.

[3]  Dino Moras,et al.  Aminoacyl-tRNA synthetases: Current opinion in structural biology 1992, 2:138…-142 , 1992 .

[4]  T. Endo,et al.  Current view on the structure-function relationship of postsynaptic neurotoxins from snake venoms. , 1987, Pharmacology & therapeutics.

[5]  A. Ménez,et al.  A monoclonal antibody which recognized the functional site of snake neurotoxins and which neutralizes all short‐chain variants , 1986, FEBS letters.

[6]  A. Pini,et al.  Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma. , 1997, Journal of immunological methods.

[7]  A. Ménez,et al.  Three‐dimensional crystal structure of recombinant erabutoxin a at 2.0 Å resolution , 1994, FEBS letters.

[8]  R. Frank,et al.  SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes. , 1996, Methods in molecular biology.

[9]  J. Lindstrom,et al.  Production and assay of antibodies to acetylcholine receptors. , 1981, Methods in enzymology.

[10]  M. Rustici,et al.  Binding of HIV‐1 gp120 to the nicotinic receptor , 1992, FEBS letters.

[11]  A. Pini,et al.  Design and Use of a Phage Display Library , 1998, The Journal of Biological Chemistry.

[12]  R L Stanfield,et al.  Antibody-antigen interactions: new structures and new conformational changes. , 1994, Current opinion in structural biology.

[13]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[14]  S. Ballas,et al.  Molecular mimicry between the rabies virus glycoprotein and human immunodeficiency virus-1 GP120: cross-reacting antibodies induced by rabies vaccination. , 1997, Blood.

[15]  M. Rustici,et al.  Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor. , 1988, Molecular immunology.

[16]  I. Tsigelny,et al.  Identification of Pairwise Interactions in the α-Neurotoxin-Nicotinic Acetylcholine Receptor Complex through Double Mutant Cycles* , 1998, The Journal of Biological Chemistry.

[17]  T. Werge,et al.  Identifying a putative common binding site shared by substance P receptor and an anti-substance P monoclonal antibody. , 1995, Protein engineering.

[18]  S. Zinn-Justin,et al.  The Functional Architecture of an Acetylcholine Receptor-mimicking Antibody* , 1997, The Journal of Biological Chemistry.

[19]  C. Gotti,et al.  Human neuronal nicotinic receptors , 1997, Progress in Neurobiology.

[20]  G. Jayaraman,et al.  Solution Structure of Toxin b, a Long Neurotoxin from the Venom of the King Cobra (Ophiophagus hannah)* , 1997, The Journal of Biological Chemistry.

[21]  R. Karlsson,et al.  Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.

[22]  S. Zinn-Justin,et al.  Mimicry between Receptors and Antibodies , 1996, The Journal of Biological Chemistry.

[23]  A. Ménez,et al.  Variability among the Sites by Which Curaremimetic Toxins Bind to Torpedo Acetylcholine Receptor, as Revealed by Identification of the Functional Residues of α-Cobratoxin* , 1999, The Journal of Biological Chemistry.

[24]  H. Arias,et al.  Topology of ligand binding sites on the nicotinic acetylcholine receptor , 1997, Brain Research Reviews.

[25]  E. Hawrot,et al.  Binding of rabies virus to purified Torpedo acetylcholine receptor. , 1986, Brain research.

[26]  J. Changeux,et al.  Nicotinic receptor: an allosteric protein specialized for intercellular communication , 1995 .